| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.983 | 4.719 | 10.956 | 9.882 | 2.254 | 2.915 | 5.704 | 2.312 | 4.062 | 5.500 |
| Total Income - EUR | 4.983 | 4.719 | 10.956 | 9.882 | 2.275 | 2.915 | 5.704 | 2.312 | 4.062 | 5.500 |
| Total Expenses - EUR | 4.751 | 3.683 | 8.175 | 8.773 | 6.040 | 4.819 | 6.751 | 7.413 | 7.607 | 7.124 |
| Gross Profit/Loss - EUR | 232 | 1.035 | 2.781 | 1.109 | -3.765 | -1.904 | -1.047 | -5.101 | -3.545 | -1.624 |
| Net Profit/Loss - EUR | 83 | 894 | 2.452 | 813 | -3.834 | -1.986 | -1.218 | -5.168 | -3.545 | -1.624 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dermasan Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.122 | 1.208 | 561 | 2.279 | 2.002 | 4.126 | 3.404 | 2.782 | 2.143 | 1.503 |
| Current Assets | 11.156 | 12.839 | 18.919 | 15.339 | 11.566 | 7.327 | 6.572 | 2.088 | 1.308 | 610 |
| Inventories | 619 | 612 | 0 | 273 | 268 | 361 | 353 | 354 | 353 | 351 |
| Receivables | 4.499 | 4.454 | 4.829 | 4.741 | 4.649 | 2.059 | 2.013 | 152 | 189 | 151 |
| Cash | 6.038 | 7.773 | 14.090 | 10.325 | 6.649 | 4.907 | 4.206 | 1.581 | 766 | 108 |
| Shareholders Funds | 18.511 | 19.216 | 21.343 | 19.356 | 15.148 | 12.875 | 11.371 | 6.238 | 2.674 | 1.036 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 125 | 134 | 172 | 258 | 378 | 499 | 483 | 516 | 2.655 | 2.946 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Dermasan Srl